These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36478760)

  • 81. Medication persistence rates and factors associated with persistence in patients following stroke: a cohort study.
    Lummis HL; Sketris IS; Gubitz GJ; Joffres MR; Flowerdew GJ
    BMC Neurol; 2008 Jul; 8():25. PubMed ID: 18616796
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Medication compliance for secondary prevention and long-term outcome among patients with acute coronary syndrome after percutaneous coronary intervention in different regions].
    Wang X; Li Y; Li J; Qiu MH; Qi ZZ; Li XY; Li YZ; Na K; Han YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Feb; 49(2):143-149. PubMed ID: 33611900
    [No Abstract]   [Full Text] [Related]  

  • 83. Evidence for age and sex differences in the secondary prevention of stroke in Scottish primary care.
    Simpson CR; Wilson C; Hannaford PC; Williams D
    Stroke; 2005 Aug; 36(8):1771-5. PubMed ID: 16040591
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Influence of on-going treatment with angiotensin-converting enzyme inhibitor or angiotensin receptor blocker on the outcome of patients treated with intravenous rt-PA for ischemic stroke.
    Gilliot S; Sibon I; Mas JL; Moulin T; Béjot Y; Cordonnier C; Giroud M; Odou P; Bordet R; Vivien D; Leys D;
    J Neurol; 2018 May; 265(5):1166-1173. PubMed ID: 29549467
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Ischemic stroke and secondary prevention in clinical practice: a cohort study of 14,529 patients in the Swedish Stroke Register.
    Asberg S; Henriksson KM; Farahmand B; Asplund K; Norrving B; Appelros P; Stegmayr B; Asberg KH; Terént A
    Stroke; 2010 Jul; 41(7):1338-42. PubMed ID: 20522818
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effect of antiplatelet persistence on long-term mortality and predictors of non-persistence in ischemic stroke patients 75 years and older: a nationwide cohort study.
    Kim SJ; Kwon OD; Choi HC; Lee EJ; Cho B
    BMC Geriatr; 2021 Apr; 21(1):232. PubMed ID: 33827445
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Processes of Care Associated With Risk of Mortality and Recurrent Stroke Among Patients With Transient Ischemic Attack and Nonsevere Ischemic Stroke.
    Bravata DM; Myers LJ; Reeves M; Cheng EM; Baye F; Ofner S; Miech EJ; Damush T; Sico JJ; Zillich A; Phipps M; Williams LS; Chaturvedi S; Johanning J; Yu Z; Perkins AJ; Zhang Y; Arling G
    JAMA Netw Open; 2019 Jul; 2(7):e196716. PubMed ID: 31268543
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Baseline Prescription and One-Year Persistence of Secondary Prevention Drugs after an index Stroke in Central Ghana.
    Sarfo FS; Ovbiagele B; Akassi J; Kyem G
    eNeurologicalSci; 2017 Mar; 6():68-73. PubMed ID: 28920085
    [TBL] [Abstract][Full Text] [Related]  

  • 90. ERRATUM to Immigration status and utilization of secondary preventive treatment after ischemic stroke.
    Eur Stroke J; 2023 Mar; 8(1):410. PubMed ID: 37021187
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Danish Medical Statistics.
    West J Med Surg; 1841 Jan; 3(1):64. PubMed ID: 38207717
    [No Abstract]   [Full Text] [Related]  

  • 92. Oral anticoagulation therapy initiation in patients with atrial fibrillation in relation to world region of origin: a register-based nationwide study.
    Frydenlund J; Valentin JB; Norredam M; Frost L; Riahi S; Kragholm KH; Bøggild H; Lip GYH; Johnsen SP
    Open Heart; 2024 Mar; 11(1):. PubMed ID: 38553012
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Processes of Care and Associated Factors in Patients With Stroke by Immigration Status.
    Mkoma GF; Johnsen SP; Agyemang C; Hedegaard JN; Iversen HK; Andersen G; Norredam M
    Med Care; 2023 Mar; 61(3):120-129. PubMed ID: 36603146
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Antidepressant utilization after hospitalization with depression: a comparison between non-Western immigrants and Danish-born residents.
    Wallach-Kildemoes H; Thomsen LT; Kriegbaum M; Petersen JH; Norredam M
    BMC Psychiatry; 2014 Mar; 14():77. PubMed ID: 24636339
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
    Høgh AL
    Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease.
    Baker WL; Coleman CI; Kluger J; Reinhart KM; Talati R; Quercia R; Phung OJ; White CM
    Ann Intern Med; 2009 Dec; 151(12):861-71. PubMed ID: 20008762
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Immigration status and utilization of secondary preventive treatment after ischemic stroke.
    Mkoma GF; Johnsen SP; Iversen HK; Andersen G; Norredam M
    Eur Stroke J; 2022 Dec; 7(4):402-412. PubMed ID: 36478760
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Use of reperfusion therapy and time delay in patients with ischaemic stroke by immigration status: A register-based cohort study in Denmark.
    Mkoma GF; Norredam M; Iversen HK; Andersen G; Johnsen SP
    Eur J Neurol; 2022 Jul; 29(7):1952-1962. PubMed ID: 35212085
    [TBL] [Abstract][Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.